This symposium will examine key metrics within the clinical trial initiation process, and the first presentation will present the results of aggregate company data. Data from studies completed during 2008-2011 were analyzed across study and site level. A second presentation will examine those strategies and approaches that drive efficiencies during study startup including protocol review, targeted site identification and streamlined regulatory document collection. The third presentation will examine various solutions to conduct efficient investigator meetings.